Sign In
Buy OPY
$106.64
-4.06 (-3.67%)
At Close: Jul 31, 2026
Fortive Corporation $FTV Shares Bought by Oppenheimer Asset Management Inc.
03:35am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. raised its holdings in Fortive Corporation (NYSE: FTV) by 89.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securi
Oppenheimer on Meta downgrade: Significant AI investments despite unknown revenues
01:23pm, Friday, 31'st Oct 2025
Jason Helfstein, Oppenheimer head of internet research, joins 'The Exchange' to discuss the firm's downgrade of Meta, what's distinguishing it from Alphabet and much more.
Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings
08:00am, Friday, 31'st Oct 2025
NEW YORK , Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quart
Addition of respected industry veteran highlights the rapid expansion of the firm's Public Finance team NEW YORK , Oct. 29, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer"), a leading inves
Viridian Therapeutics (NASDAQ:VRDN) Sees Large Volume Increase Following Analyst Upgrade
01:58am, Thursday, 23'rd Oct 2025
Viridian Therapeutics, Inc. (NASDAQ: VRDN - Get Free Report) saw strong trading volume on Wednesday after Oppenheimer raised their price target on the stock from $32.00 to $36.00. Oppenheimer currentl
Hamilton Lane upgraded to Outperform from Perform at Oppenheimer
06:41am, Tuesday, 14'th Oct 2025
Oppenheimer analyst Chris Kotowski upgraded Hamilton Lane to Outperform from Perform with an $181 price target. 11 Feb 03 Sep
Ares Management upgraded to Outperform from Perform at Oppenheimer
06:41am, Tuesday, 14'th Oct 2025
Oppenheimer upgraded Ares Management to Outperform from Perform with an $180 price target. 03 Nov
Oppenheimer Holdings: Investment Banking Results On A Good Trend
10:27am, Monday, 13'th Oct 2025
Oppenheimer delivered a strong quarter, benefiting from a capital and securities market recovery, increased AUM, and robust sales and trading activity. OPY trades at a low P/E and P/B, it's clearly qu
Retailers to face cost struggle if tariffs on China increase: Oppenheimer's Nagel
05:04pm, Friday, 10'th Oct 2025
CNBC's “Closing Bell Overtime” team discusses the market sell-off following President Donald Trump's threat of higher tariffs on China and the retail stocks hit the hardest with Brian Nagel, senio
Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
06:00am, Monday, 06'th Oct 2025
Seasoned industry professional brings 27 years of experience to expanding Healthcare platform NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment ba
Nike is reinvigorated under new management, but risks remain, says Oppenheimer's Brian Nagel
05:05pm, Tuesday, 30'th Sep 2025
Brian Nagel, Oppenheimer senior equity research analyst, joins Closing Bell Overtime to break down Nike's quarterly earnings beat, stronger-than-expected revenue, improving gross margins and expense c
Oppenheimer Expands Custody and Prime Services (CAPS) Platform to Meet Growing Demand from Emerging Managers
06:00am, Tuesday, 30'th Sep 2025
Firm strengthens multi-asset infrastructure and adds senior talent as part of next phase of strategic growth NEW YORK , Sept. 30, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. — a leading investment b
American Financial Group, Inc., Management to Participate in the 2025 Oppenheimer Virtual Insurance Summit
05:00pm, Thursday, 18'th Sep 2025
CINCINNATI--(BUSINESS WIRE)--American Financial Group, Inc. (NYSE: AFG) announced today that Carl H. Lindner III and S. Craig Lindner, Co-Chief Executive Officers, and Brian S. Hertzman, Senior Vice P
OPPENHEIMER EXPANDS GLOBAL CREDIT TEAM
05:00am, Wednesday, 17'th Sep 2025
New European team enhances global client coverage and collaboration, with a focus on global high yield and distressed assets LONDON , Sept. 17, 2025 /PRNewswire/ -- Oppenheimer Europe Limited (Oppenhe
MongoDB price target raised to $325 from $275 at Oppenheimer
07:47am, Wednesday, 27'th Aug 2025
Oppenheimer analyst Ittai Kidron raised the firm's price target on MongoDB to $325 from $275 and keeps an Outperform rating on the shares. The firm notes MongoDB delivered impressive Q2 results, sound
